Section Arrow
Quote
DVAX.NASDAQ
- Dynavax Technologies Corp
Quotes are at least 15-min delayed:2025/07/04 13:46 EDT
Last
 10.27
+0.11 (+1.08%)
Day High 
10.305 
Prev. Close
10.16 
1-M High
10.675 
Volume 
511.14K 
Bid
9.95
Ask
11.83
Day Low
10.12 
Open
10.13 
1-M Low
9.65 
Market Cap 
1.22B 
Currency USD 
P/E 48.45 
%Yield -- 
10-SMA 9.98 
20-SMA 10.08 
50-SMA 10.19 
52-W High 14.63 
52-W Low 9.22 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.50/0.54
Enterprise Value
1.47B
Balance Sheet
Book Value Per Share
4.42
Cash Flow
Cash Flow Yield
0.05
Income Statement
Total Revenue
277.25M
Operating Revenue Per Share
3.01
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
TLRYTilray Brands0.5387+0.0535+11.03%-- 
RGCRegencell Bioscience Holdings Limited22.99+12.63+121.91%-- 
CGCCanopy Growth Corp1.28+0.09+7.56%-- 
IXHLIncannex Healthcare0.2094+0.0025+1.21%-- 
HLNHaleon plc10.25-0.01-0.10%23.95PE
Quotes are at least 15-min delayed：2025/07/04 13:46 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Dynavax Technologies Corp is a biopharmaceutical company. The company focuses on leveraging the power of the body's innate and adaptive immune responses through toll-like receptor stimulation. Its current product candidates are being investigated for use in multiple cancer indications as a vaccine for the prevention of HEPLISAV-B (Hepatitis B Vaccine (Recombinant), Adjuvanted), operates in the business segment of discovery, development, and commercialization of novel vaccines. Its Toll-like Receptor Immune Modulation Platform technology plays a vital role in innate immunity and subsequent adaptive immunity. The company generates the vast majority of its revenue from the sale of its CpG 1018 product and HEPLISAV-B.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.